HOME > Regenerative medicine business

Introduction

BJH LTD is a London-based company developing cutting-edge technologies in the field of regenerative medicine. Regenerative medicine is a future-oriented medical treatment that enables the regeneration of damaged cells, tissues, and organs, providing a cure. BJH is tackling medical challenges around the world, striving to improve patients' quality of life and drive medical innovation.

Business domain/technical field

Stem cell therapy

・Content: Regenerative therapy using autologous and allogeneic cells

・Target diseases: arthritis, spinal cord injury, heart disease, neurological disorders, diabetes, etc.

・Technology: Cultivation and differentiation induction technology, development of personalized medicine

gene therapy

・Content: Utilizing CRISPR technology to cure genetic diseases and cancer

Strengths: High-precision gene editing, treatment for rare diseases, clinical trials for commercialization

3D bioprinting

・Content: Artificially generating organs and tissues using bioink

・Examples: Successful printing of artificial skin, mini liver, and cardiac tissue

Clinical application and dissemination support

・Contents: Returning research results to medical practice and developing patient support programs

・Partners: Collaboration with pharmaceutical companies, hospitals, and international research institutions

Features and strengths

international research collaboration

Joint development with major European research institutes and universities

Multinational team of experts

Team design combining medicine, engineering, biology, and AI

Regulatory and ethical compliance

Compliance with UK and EU medical standards, emphasis on patient rights and privacy

Global expansion ability

London-based medical hub building in collaboration with Japan and the Middle East

Sustainable

Adopting environmentally friendly technology and utilizing regenerative cell resources

Business domain/technical field

Stem cell treatment program

Cases of improved Alzheimer's symptoms/clinical application to chronic diseases

Commercialization of gene therapy

Approaches to hemophilia treatment and cancer treatment

3D Bioprinting Achievements

Commercializing the world's first functional mini-liver printing and artificial skin printing technology

Social significance and future prospects

・Realization of curative treatment: Moving from symptomatic therapy to "complete cure"

・Innovation in transplant medicine: Reducing dependence on donors

・Addressing an aging society: Restoring functions degraded by aging

・Reduction of medical costs: Alleviating the long-term treatment burden of chronic diseases

・Expansion of treatment targets: Apply regenerative medicine to a wider range of diseases

・Strengthening international expansion: Exporting technology to Japan and the Middle East

・Realization of personalized medicine: Providing individualized treatments using AI and genomic analysis

BJH LTD is shaping the future of medical technology,
We aim to create a society where patients around the world can have hope.

BJH's challenge: creating the future from cells